Literature DB >> 9336017

The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function.

E R Prossnitz1, R D Ye.   

Abstract

N-formyl peptides, such as fMet-Leu-Phe, are one of the most potent chemoattractants for phagocytic leukocytes. The interaction of N-formyl peptides with their specific cell surface receptors has been studied extensively and used as a model system for the characterization of G-protein-coupled signal transduction in phagocytes. The cloning of the N-formyl peptide receptor cDNA from several species and the identification of homologous genes have allowed detailed studies of structural and functional aspects of the receptor. Recent findings that the receptor is expressed in nonhematopoietic cells and that nonformylated peptides can activate the receptor suggest potentially novel functions and the existence of additional ligands for this receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9336017     DOI: 10.1016/s0163-7258(96)00203-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  46 in total

1.  Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis.

Authors:  G Servant; O D Weiner; E R Neptune; J W Sedat; H R Bourne
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

2.  Conjugates bearing multiple formyl-methionyl peptides display enhanced binding to but not activation of phagocytic cells.

Authors:  Shahriar Pooyan; Bo Qiu; Marion M Chan; Dunne Fong; Patrick J Sinko; Michael J Leibowitz; Stanley Stein
Journal:  Bioconjug Chem       Date:  2002 Mar-Apr       Impact factor: 4.774

3.  Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.

Authors:  Katharina Wenzel-Seifert; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-05       Impact factor: 3.000

4.  Unexpected enhancement in biological activity of a GPCR ligand induced by an oligoethylene glycol substituent.

Authors:  Chutima Jiarpinitnun; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

5.  The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR.

Authors:  Jingjing Zhu; Oumei Wang; Lingfei Ruan; Xinwei Hou; Youhong Cui; Ji Ming Wang; Yingying Le
Journal:  Int Immunopharmacol       Date:  2009-05-06       Impact factor: 4.932

6.  Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes.

Authors:  Susan M Young; Cristian M Bologa; Dan Fara; Bj K Bryant; Juan Jacob Strouse; Jeffrey B Arterburn; Richard D Ye; Tudor I Oprea; Eric R Prossnitz; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

7.  Focal adhesion kinase regulates pathogen-killing capability and life span of neutrophils via mediating both adhesion-dependent and -independent cellular signals.

Authors:  Anongnard Kasorn; Pilar Alcaide; Yonghui Jia; Kulandayan K Subramanian; Bara Sarraj; Yitang Li; Fabien Loison; Hidenori Hattori; Leslie E Silberstein; William F Luscinskas; Hongbo R Luo
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

8.  Screening of an Echinococcus granulosus cDNA library with IgG4 from patients with cystic echinococcosis identifies a new tegumental protein involved in the immune escape.

Authors:  E Ortona; P Margutti; F Delunardo; V Nobili; E Profumo; R Riganò; B Buttari; G Carulli; A Azzarà; A Teggi; F Bruschi; A Siracusano
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 9.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

10.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.